Clinical Trial Update: Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer

View source ↗

Summary

A retrospective Brazilian study evaluated fulvestrant in advanced breast cancer, reporting observational outcomes on its effectiveness and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Faslodex (fulvestrant)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED